Correspondence 0001477932-22-008657 from BIOADAPTIVES, INC. (BDPT) (CIK 0001575142) (BDPT)
BIOADAPTIVES, INC. (BDPT) (CIK 0001575142)
Date: Nov. 15, 2022 · CIK: 0001575142 · Accession: 0001477932-22-008657
AI Filing Summary & Sentiment
File numbers found in text: 024-11819
Letter
VIA EDGAR Office of Life Sciences Division of Corporation Finance Securities and Exchange Commission Re: Bioadaptives, Inc. Post Qualification Amendment No 1 to Offering Statement on Form 1A Commission File No. 024-11819
Dear Ms Sarmento:
On behalf of BioAdaptives, Inc, I respectfully request that the qualification date of this Amendment to the Offering Statement be accelerated and that the Amendment to the Offering Statement be declared qualified November 17, 2022, at 12:00 p.m. EST, or as soon thereafter as is reasonably practicable.
In making this request, the Company represents upon qualification by the Securities and Exchange Commission (the “Commission”), and acknowledges the following:
-
should the Commission or the Staff, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;
-
the action of the Commission or the staff, acting pursuant to delegated authority, to declare the filing qualified does not relieve the Company from its full responsibility for the adequacy and accuracy of disclosure in the filing; and
-
the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities law of the United States.
Very truly yours,
/s/ Edward E. Jacobs, Jr.
Show Raw Text
CORRESP
1
filename1.htm
bdpt_corresp.htmBIOADAPTIVES, INC.
2620 Regatta Drive, Suite 102
Las Vegas, Nevada 89128
November 15, 2022
VIA EDGAR
Ada D. Sarmento
Office of Life Sciences
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
Bioadaptives, Inc.
Post Qualification Amendment No 1 to Offering Statement on Form 1A
Commission File No. 024-11819
Dear Ms Sarmento:
On behalf of BioAdaptives, Inc, I respectfully request that the qualification date of this Amendment to the Offering Statement be accelerated and that the Amendment to the Offering Statement be declared qualified November 17, 2022, at 12:00 p.m. EST, or as soon thereafter as is reasonably practicable.
In making this request, the Company represents upon qualification by the Securities and Exchange Commission (the “Commission”), and acknowledges the following:
-
should the Commission or the Staff, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;
-
the action of the Commission or the staff, acting pursuant to delegated authority, to declare the filing qualified does not relieve the Company from its full responsibility for the adequacy and accuracy of disclosure in the filing; and
-
the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities law of the United States.
Very truly yours,
/s/ Edward E. Jacobs, Jr.
Edward E. Jacobs, Jr., MD
Chief Executive Officer
Bioadaptives, Inc.